|
| volgende >> |
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
Details van artikel 1 van 5 gevonden artikelen
| Titel: |
Bioequivalence of Follow-on Biologics or Biosimilars |
| Auteur: |
Yellela Sri Rama Krishnaiah |
| Verschenen in: |
Journal of bioequivalence & bioavailability |
| Paginering: | Jaargang 01 (2009) nr. 02 pagina's i-ii |
| Jaar: |
2009 |
| Inhoud: |
The patents for a large number of the first generationbiopharmaceutical drugs or biologics are getting expired, and thus opening the doors for generic competition. It is a fact that these biopharmaceutical drugs have become an important part of pharmacotherapy in treating the so-called incurable or orphan diseases such as cancers and genetic diseases. However, these miracle drugs are highly expensive adding a lot to the health-care costs. At the same time, the blockbuster status of these biologics driving several generic drug manufacturers and large pharmaceutical industries to produce follow-on biologics or biosimilars. The term “follow-on biologics (FoB)” is used in United States while the term “biosimilars” is used in the European Union. Over a dozen biosimilars are approved across the world, mainly in Europe. |
| Uitgever: |
OMICS Publishing Group (provided by DOAJ) |
| Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
Details van artikel 1 van 5 gevonden artikelen
| volgende >> |